Litigation Details for JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2021)
✉ Email this page to a colleague
JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-10-14 |
| Court | District Court, D. New Jersey | Date Terminated | 2022-01-07 |
| Cause | 35:145 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 10,143,693 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-10-14 | 1 | Complaint | infringement of United States Patent No. 10,143,693 (the “’693 Patent”). 2. This…United States Patent & Trademark Office. JNV owns the ’693 patent. A copy of the ’693 Patent is attached…12. This is an action for patent infringement arising under the Patent Laws of the United States, … THE PATENT-IN-SUIT 45. On December 4, 2018, the ’693 Patent, titled “Dosing…of the ’693 Patent. 55. Mylan has actual knowledge of the ’693 Patent, as shown by | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
